Skip to content

Predictors of Speech Ability in Down Syndrome

Predictors of Speech Ability in Down Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05016037
Enrollment
18
Registered
2021-08-23
Start date
2022-02-14
Completion date
2025-04-30
Last updated
2025-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Speech Intelligibility Intervention in Down Syndrome

Brief summary

Speech is a critical aspect of the human experience and usually develops in a seemingly automatic process that continues from birth through adolescence and underlies many related abilities (e.g., language and reading, see National Academy of Medicine Report on Speech and Language Disorders, 2016). Many individuals with Down Syndrome (Trisomy 21, DS) struggle to communicate and participate more fully in human communication and educational learning experiences because their speech is difficult to understand. The purpose of the proposed project was to measure speech-articulation accuracy and speech intelligibility, and their proposed primary predictors at study entry in 16 children with DS age 4;0 to 17;11). A validated treatment, speech recast intervention (see Yoder, Camarata & Woynaroski, 2016) was used to drive growth in speech intelligibility as a means of evaluating changes in potential sequelae of change. This study included measures of speech-articulation accuracy, and speech-prosody skills as predictors of speech intelligibility growth in DS.

Detailed description

In most children, speech development progresses in a seemingly automatic manner that continues from birth through adolescence1 and supports related communication and reading abilities. But many individuals with Down Syndrome (DS, about 1 in 700 births in the US) struggle to acquire speech and participate more fully in human communication and gain access to learning experiences, in part, because their speech is often difficult to understand. This persistent speech disorder arises because people with DS must acquire and produce speech using structurally-different articulators and poor speech oral-motor abilities. Moreover, there is considerable variability in the speech intelligibility of people with DS and it is unclear why some people with DS communicate relatively proficiently whereas others are unable to clearly communicate. The Investigator's recent research provides a unique combination of findings that, when integrated into a prospective project, can potentially provide new insights into how people with DS improve speech intelligibility. This assertion is grounded in the long-standing and replicated finding that speech intelligibility in DS is not strongly correlated with nor solely attributable to measures of phoneme production, so that improvements in intelligibility must rely not only improvements in speech accuracy (phoneme production) but also upon changes in nonphonemic factors such as cognitive-linguistic parameters and suprasegmental features such as prosody and speech rate that are currently poorly understood. For example, in a recent paper (Wilson, Abedduto, Camarata & Shriberg, 2019), the Investigators describe cognitive/linguistic and speech-motor factors that relate to speech intelligibility in DS and provide preliminary data on nonphonemic parameters that are significantly correlated to intelligibility. In the cognitive linguistic domain, the Investigators found that measures of cognitive ability and receptive language abilities were directly related to speech intelligibility in people with DS. The Investigators also found that measures of speech-motor ability related to speech intelligibility. Importantly, in another series of studies, the Investigators demonstrated that individualized lexically based phonological recast intervention resulted in improvements in speech intelligibility in school age children with DS and that these gains were NOT uniquely attributable to changes in speech accuracy (phoneme production). Thus, the Investigators propose to induce growth in speech intelligibility in order to study change in speech and as an important step towards a) developing more effective speech interventions, and b) gaining a better understanding of parameters that drive improved speech intelligibility in DS (e.g.,phoneme production). This latter point is especially important because the Investigator's previous research and the extant literature indicate that traditional measures of speech accuracy (e.g., phoneme articulation) do not completely capture or predict improvements in speech intelligibility in DS. The proposed research would thus test assumptions underlying current models of speech disorder (and intervention) in DS. The Investigator's previous research has indicated that the Investigators can drive change in speech intelligibility without directly targeting speech accuracy, providing an opportunity to study intelligibility while controlling for speech accuracy as an untreated factor. Thus, an important first step in identifying factors that influence variation in speech intelligibility in addition to speech accuracy is to identify predictors of these speech abilities following intervention induced gains. Therefore, in keeping with the goals of an exploratory/developmental research project proposal (R21), the Investigators propose a pre-post design that measures speech intelligibility, and it's posited sequelae within the context of a controlled pre-post speech recast intervention study. Participants were 16 school-age children (4 to 17 years) with DS with varied cognitive ability levels (minimum of 60 with no ceiling). The following specific aims were pursued: Aim 1: Test whether there were changes in baseline to post intervention measures of speech. Aim 2: Examine the associations among measures of speech accuracy and prosody and overall speech intelligibility. Impact: The results of this study within the context of a pre-post intervention design will provide important preliminary information on factors that contribute to intelligible speech in DS; thereby informing models of speech intelligibility and speech accuracy and future larger scale clinical trials. The proposed project will provide preliminary data to guide future longitudinal studies of value-added predictors of speech outcomes, and ultimately, improve assessment and intervention for speech deficits in individuals with DS.

Interventions

BEHAVIORALLexically based speech recast

A child's spontaneous or elicited word production containing phonological errors is immediately followed with a clinician verbal model that corrects the error(s) at the word level rather than the isolated phoneme level. As an example, a speech recast of child's production of the word bake as \[be\] would be the whole lexeme bake \[bek\] rather than production drill on \[k\] in isolation.

Sponsors

National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH
Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* previous medical identification of Down Syndrome * chronological age 4-17 years * regular use of 3-word utterances (ascertained via parent report during screening and confirmed during assessments) * pass a hearing screening at the time of enrollment in the project. All will pass a hearing screening (25 dB @1000, 2000, 4000 Hz).

Exclusion criteria

A history of or parent report of * seizures, * diagnosed ADHD, * apraxia secondary to a diagnosed neurological disorder * Autism Spectrum Disorder (Autism Diagnostic Observation Scale-2nd Edition score above the ASD cut-off) or * severe disruptive behavior that would prevent participation in testing or treatment.

Design outcomes

Primary

MeasureTime frameDescription
Speech Intelligibilitysix monthsSpeech intelligibility is a 5 point Likert scale based on the language sample obtained (e.g., based on the number of words spoken in the sample). The scale range is 1 to 5, 1 being very low intelligibility and 5 being high intelligibility.
Speech Accuracysix monthsPercentage of correct phonemes on standardized speech tests and in a semi structured speech sample. This is the number of correct phonemes divided by the number of total phonemes in the sample (or test) divided by 100.

Countries

United States

Participant flow

Participants by arm

ArmCount
Baseline Measures
Baseline Measures and Demographic Information
17
Total17

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up2

Baseline characteristics

CharacteristicBaseline Measures
Age, Categorical
<=18 years
17 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Arizona Articulation and Phonology Scale-4th Edition57.5 Standard Score
STANDARD_DEVIATION 2.1
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
15 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
Expressive One Word Picture Vocabulary Test (EOWPVT-4)73.7 standard score
STANDARD_DEVIATION 10.5
Leiter International Performance Scale, Third Edition71.69 Nonverbal IQ
STANDARD_DEVIATION 13.26
Mean Length of Utterance2.24 morphemes per phrase
STANDARD_DEVIATION 1.17
Percent Consonants Correct61.81 Percent Consonants Correct
STANDARD_DEVIATION 20.45
Percent Vowels Correct88.82 Percent Vowels Correct
STANDARD_DEVIATION 9.37
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
11 Participants
Receptive One Word Picture Vocabulary Test (ROWPVT-4)74.75 Standard Score
STANDARD_DEVIATION 13.42
Region of Enrollment
United States
17 participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
10 Participants
Speech Intelligibility3.53 score on a scale
STANDARD_DEVIATION 1.18
Test for Auditory Comprehension of Language - 4th Edition (TACL-4)
Elaborated Phrases and Sentences
46.56 standard score
STANDARD_DEVIATION 15.66
Test for Auditory Comprehension of Language - 4th Edition (TACL-4)
Grammatical Morphemes
47.12 standard score
STANDARD_DEVIATION 16.6
Test for Auditory Comprehension of Language - 4th Edition (TACL-4)
Vocabulary Subtest
52.06 standard score
STANDARD_DEVIATION 24.74
Woodcock Camarata Articulation Battery (WCAB)32.56 standard score
STANDARD_DEVIATION 15.43

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 18
other
Total, other adverse events
0 / 18
serious
Total, serious adverse events
0 / 18

Outcome results

Primary

Speech Accuracy

Percentage of correct phonemes on standardized speech tests and in a semi structured speech sample. This is the number of correct phonemes divided by the number of total phonemes in the sample (or test) divided by 100.

Time frame: six months

Population: One participant did not complete the final speech accuracy measure. The patient declined (refused) to complete the test. The assent rules require that the study team stop testing if a child indicates they do not want to do a test.

ArmMeasureGroupValue (MEAN)Dispersion
Lexically Based Speech Intelligibility RecastSpeech AccuracyPercent Consonants Correct61.55 percentage of correct phonemesStandard Deviation 17.97
Lexically Based Speech Intelligibility RecastSpeech AccuracyPercent Vowels Correct89.57 percentage of correct phonemesStandard Deviation 9.05
Primary

Speech Intelligibility

Speech intelligibility is a 5 point Likert scale based on the language sample obtained (e.g., based on the number of words spoken in the sample). The scale range is 1 to 5, 1 being very low intelligibility and 5 being high intelligibility.

Time frame: six months

ArmMeasureValue (MEAN)Dispersion
Lexically Based Speech Intelligibility RecastSpeech Intelligibility3.59 score on a scaleStandard Deviation 0.97

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026